Contact
searchSearch
HMP Global
Login

Postpartum Depression Topic Center

postpartum depression
Digital Health Interventions Show Promise in Alleviating Postpartum Depression and Anxiety
01/05/2024
Digital health interventions modestly but notably reduce postpartum depression and anxiety symptoms compared to ‘treatment as usual,’ a systematic review found.
Digital health interventions modestly but notably reduce postpartum depression and anxiety symptoms compared to ‘treatment as usual,’ a systematic review found.
Digital health interventions...
01/05/2024
Psych Congress Network
FDA building
News
FDA Approves First Oral Postpartum Depression Treatment, Zuranolone
08/07/2023
The FDA approved Zurzuvae (zuranolone) on Friday through a fast-track designation, making it the first oral medication designed for the treatment of PPD in adults.
The FDA approved Zurzuvae (zuranolone) on Friday through a fast-track designation, making it the first oral medication designed for the treatment of PPD in adults.
The FDA approved Zurzuvae...
08/07/2023
Psych Congress Network
News
Hormonal Contraception-Associated Depressive Episodes May Be Linked to PPD Risk
07/14/2023
Depression associated with hormonal contraception (HC) use may indicate susceptibility to postpartum depression (PPD), linking depressive episodes with hormonal contributions, findings published in JAMA Psychiatry suggest.
Depression associated with hormonal contraception (HC) use may indicate susceptibility to postpartum depression (PPD), linking depressive episodes with hormonal contributions, findings published in JAMA Psychiatry suggest.
Depression associated with...
07/14/2023
Psych Congress Network
News
Mothers With Depression Respond Slower to Children, Study Finds
04/24/2023
Mothers with depression take longer to respond to their infant children than mothers without depression, according to a longitudinal study published in Infant and Child Development.
Mothers with depression take longer to respond to their infant children than mothers without depression, according to a longitudinal study published in Infant and Child Development.
Mothers with depression take...
04/24/2023
Psych Congress Network
pop quiz
Quiz
Is synthetic environmental phthalate exposure linked with increased PPD risk?
03/21/2023
True or false: exposure to the synthetic environmental chemical phthalate is linked with an increased likelihood of postpartum depression.
True or false: exposure to the synthetic environmental chemical phthalate is linked with an increased likelihood of postpartum depression.
True or false: exposure to the...
03/21/2023
Psych Congress Network
News
For Postpartum Mental Health, Parental Leave Might Lessen Depressive Symptoms
01/10/2023
Common postpartum mental health issues, including depressive symptoms, might be guarded against with parental leave policies in place, according to the findings of a systematic review and meta-analysis published in The Lancet Public Health.
Common postpartum mental health issues, including depressive symptoms, might be guarded against with parental leave policies in place, according to the findings of a systematic review and meta-analysis published in The Lancet Public Health.
Common postpartum mental health...
01/10/2023
Psych Congress Network
News
Prenatal Depression Screening, Referral Improves After Online Provider Training
01/02/2023
Screening for prenatal depression and referral for care increased after providers underwent a brief online training intervention, study says.
Screening for prenatal depression and referral for care increased after providers underwent a brief online training intervention, study says.
Screening for prenatal...
01/02/2023
Psych Congress Network
News
Low Iodine Intake Associated With Risk of Perinatal and Postpartum Emotional Distress and Depression
11/08/2022
However, use of iodine supplements was also found to increase risk of emotional distress.
However, use of iodine supplements was also found to increase risk of emotional distress.
However, use of iodine...
11/08/2022
Psych Congress Network
News
Postpartum Depression Ameliorated by Lay Health Professional Visits at Home
09/01/2022
Postpartum depression intervention can be successfully delivered by lay professionals in an at-home setting, and produce a significant decline in stress and depression, according to recent study results.
Postpartum depression intervention can be successfully delivered by lay professionals in an at-home setting, and produce a significant decline in stress and depression, according to recent study results.
Postpartum depression...
09/01/2022
Psych Congress Network
News
Antipsychotics During Pregnancy Do Not Hinder Children’s Test Performance
08/22/2022
Antipsychotic prescriptions during pregnancy did not appear to be associated with standardized test scores in offspring.
Antipsychotic prescriptions during pregnancy did not appear to be associated with standardized test scores in offspring.
Antipsychotic prescriptions...
08/22/2022
Psych Congress Network
News
Digital CBT for Prenatal Insomnia May Prevent Postpartum Depression, Anxiety
01/18/2022
DCBT-I during pregnancy may prevent postpartum depression and reduce insomnia and anxiety up to 6 months postpartum, according to recent study findings.
DCBT-I during pregnancy may prevent postpartum depression and reduce insomnia and anxiety up to 6 months postpartum, according to recent study findings.
DCBT-I during pregnancy may...
01/18/2022
Psych Congress Network

News Articles

FDA building
News
FDA Approves First Oral Postpartum Depression Treatment, Zuranolone
08/07/2023
The FDA approved Zurzuvae (zuranolone) on Friday through a fast-track designation, making it the first oral medication designed for the treatment of PPD in adults.
The FDA approved Zurzuvae (zuranolone) on Friday through a fast-track designation, making it the first oral medication designed for the treatment of PPD in adults.
The FDA approved Zurzuvae...
08/07/2023
Psych Congress Network
News
Hormonal Contraception-Associated Depressive Episodes May Be Linked to PPD Risk
07/14/2023
Depression associated with hormonal contraception (HC) use may indicate susceptibility to postpartum depression (PPD), linking depressive episodes with hormonal contributions, findings published in JAMA Psychiatry suggest.
Depression associated with hormonal contraception (HC) use may indicate susceptibility to postpartum depression (PPD), linking depressive episodes with hormonal contributions, findings published in JAMA Psychiatry suggest.
Depression associated with...
07/14/2023
Psych Congress Network
News
Mothers With Depression Respond Slower to Children, Study Finds
04/24/2023
Mothers with depression take longer to respond to their infant children than mothers without depression, according to a longitudinal study published in Infant and Child Development.
Mothers with depression take longer to respond to their infant children than mothers without depression, according to a longitudinal study published in Infant and Child Development.
Mothers with depression take...
04/24/2023
Psych Congress Network
News
For Postpartum Mental Health, Parental Leave Might Lessen Depressive Symptoms
01/10/2023
Common postpartum mental health issues, including depressive symptoms, might be guarded against with parental leave policies in place, according to the findings of a systematic review and meta-analysis published in The Lancet Public Health.
Common postpartum mental health issues, including depressive symptoms, might be guarded against with parental leave policies in place, according to the findings of a systematic review and meta-analysis published in The Lancet Public Health.
Common postpartum mental health...
01/10/2023
Psych Congress Network
News
Prenatal Depression Screening, Referral Improves After Online Provider Training
01/02/2023
Screening for prenatal depression and referral for care increased after providers underwent a brief online training intervention, study says.
Screening for prenatal depression and referral for care increased after providers underwent a brief online training intervention, study says.
Screening for prenatal...
01/02/2023
Psych Congress Network
News
Low Iodine Intake Associated With Risk of Perinatal and Postpartum Emotional Distress and Depression
11/08/2022
However, use of iodine supplements was also found to increase risk of emotional distress.
However, use of iodine supplements was also found to increase risk of emotional distress.
However, use of iodine...
11/08/2022
Psych Congress Network
News
Postpartum Depression Ameliorated by Lay Health Professional Visits at Home
09/01/2022
Postpartum depression intervention can be successfully delivered by lay professionals in an at-home setting, and produce a significant decline in stress and depression, according to recent study results.
Postpartum depression intervention can be successfully delivered by lay professionals in an at-home setting, and produce a significant decline in stress and depression, according to recent study results.
Postpartum depression...
09/01/2022
Psych Congress Network
News
Antipsychotics During Pregnancy Do Not Hinder Children’s Test Performance
08/22/2022
Antipsychotic prescriptions during pregnancy did not appear to be associated with standardized test scores in offspring.
Antipsychotic prescriptions during pregnancy did not appear to be associated with standardized test scores in offspring.
Antipsychotic prescriptions...
08/22/2022
Psych Congress Network
News
Digital CBT for Prenatal Insomnia May Prevent Postpartum Depression, Anxiety
01/18/2022
DCBT-I during pregnancy may prevent postpartum depression and reduce insomnia and anxiety up to 6 months postpartum, according to recent study findings.
DCBT-I during pregnancy may prevent postpartum depression and reduce insomnia and anxiety up to 6 months postpartum, according to recent study findings.
DCBT-I during pregnancy may...
01/18/2022
Psych Congress Network
News
Migraine History Appears to Increase Risk for Peripartum Depression and Anxiety
11/24/2021
A history of migraine may be a risk factor for anxiety symptoms in mid-pregnancy and for mixed symptoms of depression and anxiety in later stages of pregnancy, according to a study published in the Journal of Affective Disorders.
A history of migraine may be a risk factor for anxiety symptoms in mid-pregnancy and for mixed symptoms of depression and anxiety in later stages of pregnancy, according to a study published in the Journal of Affective Disorders.
A history of migraine may be a...
11/24/2021
Psych Congress Network
A teddy bear against a blue background wearing a mask and stethoscope.
News
Prenatal Glucocorticoid Exposure Linked With Increased Mental Disorder Risk
01/17/2025
Prenatal exposure to glucocorticoids was associated with an increased risk of some mental disorders at age 15, according to a study published in JAMA Network Open.
Prenatal exposure to glucocorticoids was associated with an increased risk of some mental disorders at age 15, according to a study published in JAMA Network Open.
Prenatal exposure to...
01/17/2025
Psych Congress Network
A child sleeps in bed on her stomach with her mouth hanging open
News
Loudness of Snoring May Indicate Greater Hyperactivity in Children and Adolescents
01/16/2025
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Loudness of snoring, regardless...
01/16/2025
Psych Congress Network
Is it Time for a ‘Reconceptualization’ of TRD? Some Think Yes
News
Is it Time for a ‘Reconceptualization’ of TRD? Some Think Yes
01/14/2025
Treatment-resistant depression (TRD) may be a more complex and multifaceted condition than previously thought, with authors of a recent study calling for a “unified definition and reconceptualization” of the illness. Their findings were...
Treatment-resistant depression (TRD) may be a more complex and multifaceted condition than previously thought, with authors of a recent study calling for a “unified definition and reconceptualization” of the illness. Their findings were...
Treatment-resistant depression...
01/14/2025
Psych Congress Network
Veterans’ OUD Diagnoses Increased From 2005 to 2017, Then Declined
News
Veterans’ OUD Diagnoses Increased From 2005 to 2017, Then Declined
01/14/2025
The prevalence of OUD diagnoses increased from 2005 to 2017, peaked in 2017, and then declined until 2022, according to a recent cross-sectional study of national Veterans Health Administration (VHA) electronic health record data published in...
The prevalence of OUD diagnoses increased from 2005 to 2017, peaked in 2017, and then declined until 2022, according to a recent cross-sectional study of national Veterans Health Administration (VHA) electronic health record data published in...
The prevalence of OUD diagnoses...
01/14/2025
Psych Congress Network
News
Meta-Analysis Finds Little Support for Neurofeedback for ADHD
01/13/2025
Neurofeedback did not show meaningful clinical or neuropsychological benefit for individuals with attention-deficit/hyperactivity disorder (ADHD), according to results from a systematic review and meta-analysis published print in JAMA...
Neurofeedback did not show meaningful clinical or neuropsychological benefit for individuals with attention-deficit/hyperactivity disorder (ADHD), according to results from a systematic review and meta-analysis published print in JAMA...
Neurofeedback did not show...
01/13/2025
Psych Congress Network
US FDA sign
News
Posdinemab Granted Fast Track Designation by the FDA for Early Alzheimer Disease
01/10/2025
Posdinemab, a phosphorylated tau-directed monoclonal antibody (mAb) being studied for the treatment of early Alzheimer disease (AD), was granted Fast Track designation by the US Food and Drug Administration (FDA).
Posdinemab, a phosphorylated tau-directed monoclonal antibody (mAb) being studied for the treatment of early Alzheimer disease (AD), was granted Fast Track designation by the US Food and Drug Administration (FDA).
Posdinemab, a phosphorylated...
01/10/2025
Psych Congress Network
Minority of Patients With OUD Develop PW After Buprenorphine Initiation
News
Minority of Patients With OUD Develop PW After Buprenorphine Initiation
01/08/2025
A small group of patients with OUD developed buprenorphine-precipitated withdrawal (PW) in emergency department or hospital settings, according to recent retrospective cohort study results published in JAMA Network Open.
A small group of patients with OUD developed buprenorphine-precipitated withdrawal (PW) in emergency department or hospital settings, according to recent retrospective cohort study results published in JAMA Network Open.
A small group of patients with...
01/08/2025
Psych Congress Network
Methylphenidate or Atomoxetine Maintenance Safe During Pregnancy
News
Methylphenidate or Atomoxetine Maintenance Safe During Pregnancy
01/08/2025
Maintenance of methylphenidate or atomoxetine may be safe during pregnancy, according to recent systematic review and meta-analysis results published in JAMA Network Open. 
Maintenance of methylphenidate or atomoxetine may be safe during pregnancy, according to recent systematic review and meta-analysis results published in JAMA Network Open. 
Maintenance of methylphenidate...
01/08/2025
Psych Congress Network
brain waves schizophrenia transcranial magnetic stimulation
News
Review Questions Utility of tDCS for Cognitive Symptoms in Schizophrenia
01/08/2025
A recent meta-analysis questions the effectiveness of transcranial direct current stimulation (tDCS) for improving cognitive impairments in individuals with schizophrenia after finding no statistically significant difference in cognitive...
A recent meta-analysis questions the effectiveness of transcranial direct current stimulation (tDCS) for improving cognitive impairments in individuals with schizophrenia after finding no statistically significant difference in cognitive...
A recent meta-analysis questions...
01/08/2025
Psych Congress Network
Major Depressive Disorder MDD
News
Hypomanic Symptoms in Major Depression Linked With Treatment Resistance
01/03/2025
Common in patients with unipolar depression, hypomanic symptoms are associated with both treatment-resistant depression and reduced remission of suicidal thoughts, according to a study in the Journal of Affective Disorders.
Common in patients with unipolar depression, hypomanic symptoms are associated with both treatment-resistant depression and reduced remission of suicidal thoughts, according to a study in the Journal of Affective Disorders.
Common in patients with unipolar...
01/03/2025
Psych Congress Network

Interactive Features

pop quiz
Quiz
Is synthetic environmental phthalate exposure linked with increased PPD risk?
03/21/2023
True or false: exposure to the synthetic environmental chemical phthalate is linked with an increased likelihood of postpartum depression.
True or false: exposure to the synthetic environmental chemical phthalate is linked with an increased likelihood of postpartum depression.
True or false: exposure to the...
03/21/2023
Psych Congress Network
Quiz
Quiz
What percentage of people experience hypomanic symptoms during an MDD episode?
01/15/2025
According to a recent study published in the Journal of Affective Disorders, what percentage of people experienced hypomanic symptoms during a major depressive disorder (MDD) episode?
According to a recent study published in the Journal of Affective Disorders, what percentage of people experienced hypomanic symptoms during a major depressive disorder (MDD) episode?
According to a recent study...
01/15/2025
Psych Congress Network
Which U.S. region saw the most fentanyl pill seizures in 2023?
Quiz
Which US region saw the most fentanyl pill seizures in 2023?
01/15/2025
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
01/15/2025
Psych Congress Network
An illustration of a pencil marking answers on a quiz sheet.
Expert Insights Quiz
Resources for Telehealth Rules and Regulations
01/06/2025
Test your knowledge with this quiz!
Test your knowledge with this quiz!
Test your knowledge with this...
01/06/2025
Psych Congress Network
How long does worry need to be present in order to diagnose GAD?
Quiz
How long does worry need to be present in order to diagnose GAD?
01/03/2025
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
01/03/2025
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
Antidepressant Discontinuation Symptoms
12/23/2024
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
12/23/2024
Psych Congress Network
Four people ponder with question marks over their heads
Quiz
Prodromal Symptoms in Schizophrenia
12/18/2024
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
12/18/2024
Psych Congress Network
Are men or women more affected by depressive episodes?
Quiz
Are men or women more affected by depressive episodes?
12/17/2024
Pop quiz!
Pop quiz!
Pop quiz!
12/17/2024
Psych Congress Network
After how many months is 'problematic' opioid use diagnosed as OUD?
Quiz
After how many months is 'problematic' opioid use diagnosed as OUD?
12/16/2024
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
12/16/2024
Psych Congress Network
DSM-5
Quiz
How does the DSM-5 define 'remission' in MDD?
12/13/2024
Quiz! What is the definition of remission in the context of major depressive disorder (MDD), according to the DSM-5-TR?
Quiz! What is the definition of remission in the context of major depressive disorder (MDD), according to the DSM-5-TR?
Quiz! What is the definition of...
12/13/2024
Psych Congress Network
DSM-5
Quiz
How does the chronicity of depressive symptoms affect MDD treatment and outcomes?
12/11/2024
12/11/2024
Psych Congress Network

Blogs

Blog
Screening for Perinatal Depression Is Not Enough
07/11/2018
BLOG: The logical endpoint of population-based screening for perinatal depression is remission of depression in those who screen positive. Otherwise screening is just an empty endeavor.
BLOG: The logical endpoint of population-based screening for perinatal depression is remission of depression in those who screen positive. Otherwise screening is just an empty endeavor.
BLOG: The logical endpoint...
07/11/2018
Psych Congress Network
Blog
Mothers Are Falling Through the Cracks: Let’s Make a Net for Them
04/26/2018
BLOG: On January 18, 2018, in Sacramento California, new mother Jessica Porten went to see a women’s health nurse practitioner. She was 4 months postpartum and had not been seen by her obstetric provider since giving birth.
BLOG: On January 18, 2018, in Sacramento California, new mother Jessica Porten went to see a women’s health nurse practitioner. She was 4 months postpartum and had not been seen by her obstetric provider since giving birth.
BLOG: On January 18, 2018, in...
04/26/2018
Psych Congress Network
Blog
Seeking Treatment for Postpartum Depression
05/14/2014
My postpartum depression and anxiety went undiagnosed for six months, despite my protests to my doctor.
My postpartum depression and anxiety went undiagnosed for six months, despite my protests to my doctor.
My postpartum depression and...
05/14/2014
Psych Congress Network
marc agronin md
Blog
Alzheimer Disease Prevention: Part 2
07/29/2024
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated...
07/29/2024
Psych Congress Network
Rakesh Amin, MD.
Blog
Treating Schizophrenia: The Importance of Early Identification and Intervention
06/13/2023
Rakesh Amin, MD, discusses the importance of partnering with patients and caregivers to set treatment goals and the importance of introducing long-acting injectables earlier in the treatment of schizophrenia.
Rakesh Amin, MD, discusses the importance of partnering with patients and caregivers to set treatment goals and the importance of introducing long-acting injectables earlier in the treatment of schizophrenia.
Rakesh Amin, MD, discusses the...
06/13/2023
Psych Congress Network
Marc Agronin, MD.
Blog
Alzheimer Disease Prevention
08/30/2022
Psych Congress Network Section Editor Mark Agronin, MD, provides expert clinical insights on reducing the risk for Alzheimer disease and delaying its onset and progression.
Psych Congress Network Section Editor Mark Agronin, MD, provides expert clinical insights on reducing the risk for Alzheimer disease and delaying its onset and progression.
Psych Congress Network Section...
08/30/2022
Psych Congress Network
Ed Jones, PhD
Blog
How Our Clinicians Can Help Fix the US Health Care System
07/28/2022
Ed Jones, PhD, discusses the need for a clinical refocusing that includes broad access to psychosocial solutions and ensuring socially informed clinicians can help underserved communities.
Ed Jones, PhD, discusses the need for a clinical refocusing that includes broad access to psychosocial solutions and ensuring socially informed clinicians can help underserved communities.
Ed Jones, PhD, discusses the...
07/28/2022
Psych Congress Network
Ed Jones, PhD
Perspective
The Universal Behavior Model: A Comprehensive Approach to Integrated Care
07/21/2022
Ed Jones, PhD: "We miss this psychosocial aspect of care today...What is missing?  We need psychotherapists based in primary care, often focused on mundane issues rather than the complexities of diagnosis or treatment."
Ed Jones, PhD: "We miss this psychosocial aspect of care today...What is missing?  We need psychotherapists based in primary care, often focused on mundane issues rather than the complexities of diagnosis or treatment."
Ed Jones, PhD: "We miss this...
07/21/2022
Psych Congress Network
Chan_Khan_Digital Mental Health
Blog
Who will use it? How to Get Digital Mental Health Apps Into the Hands of Patients
04/27/2022
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, discuss how to encourage patients to use digital mental health apps.
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, discuss how to encourage patients to use digital mental health apps.
Steven Chan, MD, MBA, and Burhan...
04/27/2022
Psychiatry & Behavioral Health
Chan_Khan_Digital Mental Health
Blog
How to Navigate Quality Issues With Mental Health Apps
04/21/2022
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, navigating quality issues with digital mental health applications.
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, navigating quality issues with digital mental health applications.
Steven Chan, MD, MBA, and Burhan...
04/21/2022
Psychiatry & Behavioral Health
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Blog
How New NPs Can Find Mentors
03/04/2022
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains...
03/04/2022
Psych Congress Network
Julie Bailey
Blog
How to Be a Safe Space for Someone
02/08/2022
In this blog, Julie Bailey, LCPC, shares her insights on providing a safe space for patients to discuss these social anxieties, as well as tips to share with patients about slowly reintegrating into life after COVID-19.
In this blog, Julie Bailey, LCPC, shares her insights on providing a safe space for patients to discuss these social anxieties, as well as tips to share with patients about slowly reintegrating into life after COVID-19.
In this blog, Julie Bailey,...
02/08/2022
Psych Congress Network
major depressive disorder
Blog
The Best and Worst Changes Brought On By the Pandemic
01/31/2022
Mental health advocate, Dorothy Watson shares her insights about the impact the pandemic has had on mental health and where we go from here.
Mental health advocate, Dorothy Watson shares her insights about the impact the pandemic has had on mental health and where we go from here.
Mental health advocate, Dorothy...
01/31/2022
Psych Congress Network

Posters

Effect of Centanafadine on AISRS Over 6 Weeks of Treatment in Adults with ADHD: A Pooled Analysis of Two Phase 3 Trials
TBD
11/26/2024
Impact of Centanafadine on the ASRS After 6 Weeks of Treatment of ADHD in Adults: A Pooled Analysis of Two Phase 3 Trials
Hypothesis/Objective: To evaluate the impact of centanafadine (CTN)—a norepinephrine, dopamine, serotonin reuptake inhibitor—on patient-reported assessment of the frequency of core sympto...
11/26/2024
Adjunctive Treatment With Seltorexant Improved Patient-Reported Depressive Symptoms, Insomnia Symptoms, and Overall Health in Major Depressive Disorder With Insomnia
Background: We report secondary/exploratory endpoints assessing patient-reported depressive symptoms, insomnia symptoms, and health-related quality of life (HRQoL) from a phase 3, double-...
11/26/2024
Guiding antidepressant choice by applying deep learning approaches on individual patient-derived neurons: a window to drug efficacy in each patient
Depression treatment remains a significant clinical challenge due to the variability in patient responses to antidepressant medications. Outside of pharmacogenetic testing, established mo...
11/26/2024
Clinical effectiveness and persistence on esketamine nasal spray in patients with treatment-resistant depression overall and among transcranial magnetic stimulation-naïve subgroup
BACKGROUND: Esketamine nasal spray and transcranial magnetic stimulation (TMS) are used for treatment-resistant depression (TRD), but little is known about the sequence in which these the...
11/26/2024
Real-world clinical effectiveness of esketamine nasal spray based on the Montgomery-Asberg Depression Rating Scale (MADRS) among patients with treatment-resistant depression in the United States
BACKGROUND: Clinical trials for esketamine nasal spray in treatment resistant depression (TRD) often assess efficacy using Montgomery-Asberg Depression Rating Scale (MADRS)-based primary ...
11/26/2024
Response and remission on esketamine nasal spray in patients with treatment-resistant depression overall and among transcranial magnetic stimulation-naïve subgroup
BACKGROUND: Both esketamine nasal spray and transcranial magnetic stimulation (TMS) are indicated for treatment-resistant depression (TRD), but there are no guidelines on the sequence of...
11/26/2024
Comparison of Real-world Response and Remission among Patients with Treatment-Resistant Depression Treated with Esketamine Nasal Spray or Antipsychotic Augmentation
BACKGROUND: Esketamine nasal spray and second-generation antipsychotic augmentation (SGA) are approved therapies for treatment-resistant depression (TRD). Prospective randomized ESCAPE-TR...
11/26/2024
Effectiveness of Online Medical Education at Improving Physician Knowledge, Competence and Confidence in Identifying Patients Who May Benefit from Novel Therapies for Treatment of Major Depressive Disorder
Physicians are challenged to fully understand the pathophysiology of major depressive disorder (MDD) and identify the role of novel therapies. Individualizing treatment for patients with...
11/26/2024
MDD Treatment Selection: Online CME Illustrates Best Practices in Discussing Pharmacogenomic Testing with Patients
This study examined whether an online CME clinical demonstration module can improve learners’ self-reported clinical behaviors related to management of MDD, identifying patients who may b...
11/26/2024

Practice Tools

Saundra's Corner
Beck Depression Inventory-II (BDI-II)
01/28/2019
How to Use The Beck Depression Inventory-II (BDI-II): 1996 revision of the BDI 21-item self-report multiple-choice inventory ~ 10 minutes to...
How to Use The Beck Depression Inventory-II (BDI-II): 1996 revision of the BDI 21-item self-report multiple-choice inventory ~ 10 minutes to...
How to...
01/28/2019
Psych Congress Network
Saundra's Corner
Patient Health Questionnaire (PHQ-2)
09/30/2016
Click here for the website for PHQ-2 How to Use If response is “yes” to either question, consider administering the PHQ-9. If the response to both is “no”, the screen is...
Click here for the website for PHQ-2 How to Use If response is “yes” to either question, consider administering the PHQ-9. If the response to both is “no”, the screen is...
Click here for the website for...
09/30/2016
Psych Congress Network
Saundra's Corner
Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR-16)
09/30/2016
How to Use Quick Inventory of Depressive Symptomatology (Self-Report)  (QIDS-SR-16) has proven useful for many years as a way of determining a patient’s level of depression before, during, and after treatment. It is...
How to Use Quick Inventory of Depressive Symptomatology (Self-Report)  (QIDS-SR-16) has proven useful for many years as a way of determining a patient’s level of depression before, during, and after treatment. It is...
How to...
09/30/2016
Psych Congress Network
Saundra's Corner
Medication Adherence Rating Scale (MARS)
01/29/2019
  Click here for Medication Adherence Rating Scale (MARS) - page 7      The total score ranges from 0-10 with a higher score indicating better adherence   Strengths Self-report...
  Click here for Medication Adherence Rating Scale (MARS) - page 7      The total score ranges from 0-10 with a higher score indicating better adherence   Strengths Self-report...
  Click here for...
01/29/2019
Psych Congress Network
Saundra's Corner
Sheehan Disability Scale (SDS)
01/28/2019
Click here for website for SDS How to Use The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.  How to Score Total score 0-30 (0 unimpaired, 30 highly...
Click here for website for SDS How to Use The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.  How to Score Total score 0-30 (0 unimpaired, 30 highly...
Click here for website for SDS...
01/28/2019
Psych Congress Network
Saundra's Corner
Brief Psychiatric Rating Scale (BPRS)
01/28/2019
  How to Use The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale. The BPRS is used as part of a clinical interview in which the clinician makes...
  How to Use The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale. The BPRS is used as part of a clinical interview in which the clinician makes...
...
01/28/2019
Psych Congress Network
Saundra's Corner
The Mini International Neuropsychiatric Interview
01/28/2019
How to Use The MINI is a widely used psychiatric structured diagnostic interview instrument.  To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.   The MINI...
How to Use The MINI is a widely used psychiatric structured diagnostic interview instrument.  To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.   The MINI...
How to Use The MINI is...
01/28/2019
Psych Congress Network
Saundra's Corner
MINI Screen
01/28/2019
How to Use The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.   Click here for the website for the MINI Screen     How to...
How to Use The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.   Click here for the website for the MINI Screen     How to...
How to Use The MINI Screen...
01/28/2019
Psych Congress Network
Saundra's Corner
Patient Health Questionnaire (PHQ-9)
01/28/2019
How to Use The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use The Patient Health...
01/28/2019
Psych Congress Network
Saundra's Corner
WHO (Five) Well-Being Index (WHO-5)
01/28/2019
How to Use Five items rated on 6-point Likert scale Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use Five items rated on 6-point Likert scale Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use Five items rated...
01/28/2019
Psych Congress Network
Saundra's Corner
Beck Depression Inventory-II (BDI-II)
01/28/2019
How to Use The Beck Depression Inventory-II (BDI-II): 1996 revision of the BDI 21-item self-report multiple-choice inventory ~ 10 minutes to...
How to Use The Beck Depression Inventory-II (BDI-II): 1996 revision of the BDI 21-item self-report multiple-choice inventory ~ 10 minutes to...
How to...
01/28/2019
Psych Congress Network
Saundra's Corner
Mood Disorder Questionnaire (MDQ)
01/28/2019
How to Use The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.   The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.   The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use The Mood Disorder...
01/28/2019
Psych Congress Network
Saundra's Corner
Hamilton Anxiety Rating Scale (HAM-A)
01/28/2019
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
...
01/28/2019
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Sign Up

Psych Congress Network Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use